Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 4/20 | 0.55 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.55 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.55 |
| ▸ | EPHB4 | P54760 | 3/20 | 0.55 |
| ▸ | EGFR | P00533 | 8/20 | 0.51 |
| ▸ | SOS1 | Q07889 | 6/20 | 0.51 |
| ▸ | KRAS | P01116 | 1/20 | 0.46 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.43 |
| ▸ | RET | P07949 | 1/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.43 |
| ▸ | FLT1 | P17948 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.43 |
| ▸ | EPHB2 | P29323 | 1/20 | 0.43 |
| ▸ | KIF5B | P33176 | 1/20 | 0.43 |
| ▸ | TTBK1 | Q5TCY1 | 1/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4686907 | 0.95 | EGFR (0.57) | KDRERBB2EPHA2EPHB4EGFR | |
| SCHEMBL4690909 | 0.86 | EGFR (0.46) | KDRERBB2EPHA2EPHB4EGFR | |
| SCHEMBL4689353 | 0.81 | KDR (0.55) | KDRERBB2EPHA2EPHB4EGFR | |
| SCHEMBL4693053 | 0.80 | RET (0.62) | KDRERBB2EPHA2EPHB4RET | |
| SCHEMBL4693034 | 0.80 | RET (0.59) | KDRERBB2EPHA2EPHB4RET | |
| SCHEMBL5828725 | 0.78 | FLT1 (0.62) | KDRERBB2EPHB4EGFRRET | |
| SCHEMBL5832489 | 0.78 | FLT1 (0.62) | KDRERBB2EPHB4EGFRRET | |
| SCHEMBL4693023 | 0.78 | RET (0.61) | KDREPHA2EPHB4EGFRRET | |
| SCHEMBL4690872 | 0.78 | EGFR (0.58) | KDRERBB2EPHA2EPHB4EGFR | |
| SCHEMBL4689817 | 0.77 | SRC (0.64) | KDREGFRRETKIF5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1296973-B1 | GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES | ASTRAZENECA AB (SE) | 2008-11-05 | — | — | EP | disclosed |
| US-7001904-B1 | Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases | ASTRAZENECA AB (SE) | 2006-02-21 | — | — | US | disclosed |
| EP-1296973-A1 | GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES | AstraZeneca AB (SE) | 2003-04-02 | — | — | EP | disclosed |
| WO-2002000644-A1 | GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES | ASTRAZENECA AB (SE) | 2002-01-03 | — | — | WO | disclosed |